Functional domains, structural variations and pathogen interactions of MCP, DAF and CR1.

scientific article

Functional domains, structural variations and pathogen interactions of MCP, DAF and CR1. is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1016/S0162-3109(00)80296-9
P698PubMed publication ID10904110

P2093author name stringAtkinson JP
Hourcade D
Krych-Goldberg M
Liszewski MK
P2860cites workDecay accelerating activity of complement receptor type 1 (CD35). Two active sites are required for dissociating C5 convertasesQ22010707
Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesisQ24294595
Decay-accelerating factor CD55 is identified as the receptor for echovirus 7 using CELICS, a rapid immuno-focal cloning methodQ24306280
Cloning of decay-accelerating factor suggests novel use of splicing to generate two proteinsQ24312892
The human CD46 molecule is a receptor for measles virus (Edmonston strain)Q24317745
CD19: lowering the threshold for antigen receptor stimulation of B lymphocytesQ24338598
Inhibition of phagocytosis of complement C3- or immunoglobulin G-coated particles and of C3bi binding by monoclonal antibodies to a monocyte-granulocyte membrane glycoprotein (Mol)Q24527312
Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complementQ24613512
Structure of the human CR1 gene. Molecular basis of the structural and quantitative polymorphisms and identification of a new CR1-like alleleQ24682068
Identification of an alternative polyadenylation site in the human C3b/C4b receptor (complement receptor type 1) transcriptional unit and prediction of a secreted form of complement receptor type 1Q24682397
Human C3b/C4b receptor (CR1). Demonstration of long homologous repeating domains that are composed of the short consensus repeats characteristics of C3/C4 binding proteinsQ24682687
Crystal structure of two CD46 domains reveals an extended measles virus-binding surfaceQ27618470
New structural motifs on the chymotrypsin fold and their potential roles in complement factor BQ27620995
Three-dimensional structure of a complement control protein module in solutionQ27649903
Solution structure of a pair of complement modules by nuclear magnetic resonanceQ27731948
NMR studies of a viral protein that mimics the regulators of complement activationQ27743722
X-ray crystal structure of C3d: a C3 fragment and ligand for complement receptor 2Q27757710
A new repetitive sequence uniquely present in the decay-accelerating factor genesQ48039933
Analysis of the human regulators of complement activation (RCA) gene cluster with yeast artificial chromosomes (YACs)Q48186548
Membrane cofactor protein (MCP, CD46) in seminal plasma and on spermatozoa in normal and "sterile" subjectsQ49142470
Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen.Q52519424
The role of complement and complement receptors in induction and regulation of immunity.Q53992218
Membrane cofactor protein (MCP or CD46) is a cellular pilus receptor for pathogenic Neisseria.Q54560552
Mapping the binding domains on decay accelerating factor (DAF) for haemagglutinating enteroviruses: implications for the evolution of a DAF-binding phenotypeQ56787212
Polymorphic expression of CD46 protein isoforms due to tissue-specific RNA splicingQ57272510
Bridging the gap by AAA ATPasesQ59063561
Trophoblast/Leukocyte-Common Antigen is Expressed by Human Testicular Germ Cells and Appears on the Surface of Acrosome-Reacted Sperm1Q60686957
Molecular modeling and mechanism of action of human decay-accelerating factor.Q64945078
Ontogeny of membrane cofactor protein: phenotypic divergence in the fetal heartQ70803288
Characterization of mouse DAF on transfectant cells using monoclonal antibodies which recognize different epitopesQ73299170
Possible association of infertility with sperm-specific abnormality of CD46Q73419602
Structure-function analysis of the active sites of complement receptor type 1Q74424457
Molecular cloning, expression and characterization of the rat analogue of human membrane cofactor protein (MCP/CD46)Q78197564
C3d of complement as a molecular adjuvant: bridging innate and acquired immunityQ28272810
Solution structure of the fifth repeat of factor H: a second example of the complement control protein moduleQ28279008
A 3D model for the measles virus receptor CD46 based on homology modeling, Monte Carlo simulations, and hemagglutinin binding studiesQ30176620
Sites within the complement C3b/C4b receptor important for the specificity of ligand bindingQ30454140
Viral cell entry induced by cross-linked decay-accelerating factorQ33785545
The instructive role of innate immunity in the acquired immune responseQ34375203
Membrane cofactor protein (CD46) is a keratinocyte receptor for the M protein of the group A streptococcusQ34472351
Measles virus and C3 binding sites are distinct on membrane cofactor protein (CD46).Q34584708
Human complement C3b/C4b receptor (CR1) mRNA polymorphism that correlates with the CR1 allelic molecular weight polymorphismQ34614841
Multiple isoforms of CD46 (membrane cofactor protein) serve as receptors for measles virusQ35096691
Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55).Q35835449
Mapping of the C3b-binding site of CR1 and construction of a (CR1)2-F(ab')2 chimeric complement inhibitorQ36230727
Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyteQ36343760
Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexesQ36347257
The role of complement component C3b and its receptors in sperm-oocyte interactionQ36630669
Complement evasion strategies of microorganismsQ36705669
Molecular cloning of a complementary DNA for a membrane cofactor protein (MCP, CD46)/measles virus receptor on Vero cells and its functional characterizationQ36842224
Molecular cloning of a pig homologue of membrane cofactor protein (CD46).Q36867730
The Clearance of Immune Complexes From the Circulation of Man and Other PrimatesQ37078342
Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2Q37652278
Identification of an additional class of C3-binding membrane proteins of human peripheral blood leukocytes and cell linesQ37677073
Membrane cofactor protein with different types of N-glycans can serve as measles virus receptorQ38293491
Diversity of sites for measles virus binding and for inactivation of complement C3b and C4b on membrane cofactor protein CD46.Q38294177
The N-glycan of the SCR 2 region is essential for membrane cofactor protein (CD46) to function as a measles virus receptorQ38354701
Physiological and pathological aspects of circulating immune complexesQ38620468
The regulators of complement activation (RCA) gene clusterQ38665434
The generation of transgenic pigs as potential organ donors for humans.Q40429984
Complement in human reproduction: activation and controlQ40804738
Membrane cofactor protein (MCP; CD46): isoform-specific tyrosine phosphorylationQ40902413
Use of site-specific mutagenesis and monoclonal antibodies to map regions of CD46 that interact with measles virus H proteinQ40948506
Characterization of echoviruses that bind decay accelerating factor (CD55): evidence that some haemagglutinating strains use more than one cellular receptorQ41021933
CR1 (CD35) and CR3 (CD11b/CD18) mediate infection of human monocytes and monocytic cell lines with complement-opsonized HIV independently of CD4Q41564765
Identification and biology of cellular receptors for the coxsackie B viruses group.Q41593043
Distinct receptor and regulatory properties of recombinant mouse complement receptor 1 (CR1) and Crry, the two genetic homologues of human CR1Q41644730
Molecular cloning of a murine homologue of membrane cofactor protein (CD46): preferential expression in testicular germ cellsQ41999817
Short consensus repeat-3 domain of recombinant decay-accelerating factor is recognized by Escherichia coli recombinant Dr adhesin in a model of a cell-cell interactionQ42942040
CD46 is a cellular receptor for human herpesvirus 6.Q44613357
Cardiovirulent coxsackieviruses and the decay-accelerating factor (CD55) receptorQ44935464
Mapping of the primary binding site of measles virus to its receptor CD46.Q45760982
Measles virus recognizes its receptor, CD46, via two distinct binding domains within SCR1-2.Q45762265
Mechanism of suppression of cell-mediated immunity by measles virusQ45770172
Separation of self from non-self in the complement systemQ47688509
P433issue1-2
P304page(s)103-116
P577publication date2000-08-01
P1433published inImmunopharmacologyQ24031542
P1476titleFunctional domains, structural variations and pathogen interactions of MCP, DAF and CR1.
P478volume49

Reverse relations

cites work (P2860)
Q33389860Adenovirus capsid-display of the retro-oriented human complement inhibitor DAF reduces Ad vector-triggered immune responses in vitro and in vivo.
Q39864028Adenovirus type 11 uses CD46 as a cellular receptor
Q42638203Amino acid patterns within short consensus repeats define conserved duplicons shared by genes of the RCA complex
Q39422339Anti-Sp17 monoclonal antibody with antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity activities against human ovarian cancer cells
Q40338046Blockade of bulky lymphoma-associated CD55 expression by RNA interference overcomes resistance to complement-dependent cytotoxicity with rituximab.
Q36756850Complement in immune and inflammatory disorders: pathophysiological mechanisms
Q53942590Complement resistance of human carcinoma cells depends on membrane regulatory proteins, protein kinases and sialic acid.
Q24632001Design and development of TT30, a novel C3d-targeted C3/C5 convertase inhibitor for treatment of human complement alternative pathway-mediated diseases
Q36222203Development of complement therapeutics for inhibition of immune-mediated red cell destruction
Q36506856Dissection of functional sites in herpesvirus saimiri complement control protein homolog
Q39644772Distinct CD55 Isoform Synthesis and Inhibition of Complement-Dependent Cytolysis by Hepatitis C Virus
Q44160700Effects of the mycotoxin ochratoxin A and some of its metabolites on human kidney cell lines
Q34069057Electrostatic modeling predicts the activities of orthopoxvirus complement control proteins
Q37426876Epithelial invasion by Escherichia coli bearing Dr fimbriae is controlled by nitric oxide-regulated expression of CD55.
Q34885229Expression of complement components, receptors and regulators by human dendritic cells.
Q42639676Genomic analysis reveals a duplication of eight rather than seven short consensus repeats in primate CR1 and CR1L: evidence for an additional set shared between CR1 and CR2.
Q38315657Hepatitis C virus infection upregulates CD55 expression on the hepatocyte surface and promotes association with virus particles
Q35728873Hepatitis C virus infection: establishment of chronicity and liver disease progression
Q28217335Human Herpesvirus 6 and Measles Virus Employ Distinct CD46 Domains for Receptor Function
Q36719729Identification of a complement receptor 1 peptide for inhibition of immune hemolysis
Q30447940Identification of complement regulatory domains in vaccinia virus complement control protein
Q30448441Identification of functional domains in kaposica, the complement control protein homolog of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8)
Q42802486Interaction of Glycoprotein H of Human Herpesvirus 6 with the Cellular Receptor CD46
Q42925054Intermodule cooperativity in the structure and dynamics of consecutive complement control modules in human C1r
Q37356020Mapping of functional domains in herpesvirus saimiri complement control protein homolog: complement control protein domain 2 is the smallest structural unit displaying cofactor and decay-accelerating activities
Q54517081Melatonin attenuates inflammation and promotes regeneration in rabbits with fulminant hepatitis of viral origin.
Q91622826Molecular engineering of an efficient four-domain DAF-MCP chimera reveals the presence of functional modularity in RCA proteins
Q36179379Mutational analysis of Kaposica reveals that bridging of MG2 and CUB domains of target protein is crucial for the cofactor activity of RCA proteins
Q33755215Pathogenesis of Afa/Dr diffusely adhering Escherichia coli
Q39735958Screening of complement inhibitors: shielded baculoviruses increase the safety and efficacy of gene delivery
Q33433754Self-nonself discrimination by the complement system
Q104503342Sialylation acts as a checkpoint for innate immune responses in the central nervous system
Q92513347Spatially conserved motifs in complement control protein domains determine functionality in regulators of complement activation-family proteins
Q34127130Structure-function analysis of decay-accelerating factor: identification of residues important for binding of the Escherichia coli Dr adhesin and complement regulation
Q39730178The Afa/Dr adhesins of diffusely adhering Escherichia coli stimulate interleukin-8 secretion, activate mitogen-activated protein kinases, and promote polymorphonuclear transepithelial migration in T84 polarized epithelial cells
Q33775122The alternative complement pathway regulates pathological angiogenesis in the retina
Q33908734Variant-specific tropism of human herpesvirus 6 in human astrocytes

Search more.